DED

Trial designed with a two-week run-in period to reduce the well-known placebo effect in trials involving pain componentTop-line data from trial anticipated in Q4, 2023 LONDON and NEW YORK,…

<!-- Name:DistributionId Value:8829334 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True -->…

Randomized, controlled clinical trial data on advanced dry eye patients from the OLYMPIA trial recently published in Clinical OphthalmologyStudy authors concluded that the TearCare…

LONDON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), the biotechnology company focused on the discovery and development of novel molecules to treat…